TY  - SER
TI  - Financiación selectiva de medicamentos
SN  - 0210-5020
N1  - Este artículo se encuentra disponible en su edición impresa; Bibliografía: p.15
N2  - <<It is one thing for a medicine to be safe, effective and of good quality, and as such to be included in the Register of Pharmaceutical Specialties, and another, very different, for it to be efficient and as such must be publicly financed.>> This paragraph of the The author accurately introduces us to the central content of this Zoom; Thus, throughout the text, the factors on which the public financing of medicines will depend are analyzed, taking into account both the considerations related to industrial policy and the social well-being of a country and, consequently, its health , also depend on it-like the strictly sanitary ones.
The deep knowledge of the author on the subject and the contribution of interesting data for any reader make us highly recommend this month's article
ER  -